exarafenib   Click here for help

GtoPdb Ligand ID: 12095

Synonyms: compound 15 [Chen et al., 2024] [1] | example 14 [WO2021081375A1] | KIN-2787 | KIN2787
PDB Ligand
Compound class: Synthetic organic
Comment: We obtained the chemical structure for exarafenib from the WHO's proposed INN list 127 (21 July 2022). In this document it was described as an antineoplastic. The structure is claimed in Kinnate Biopharma's patent WO2021081375A1 [2]. This patent claims the compound as a RAF kinase inhibitor, for potential to treat cancers that are driven by RAF oncogenes. Kinnate Biopharma's pipeline includes their phase 1 pan-RAF inhibitor KIN-2787. Formal disclosure of exarafenib's chemical structure in January 2024 confirmed our name-to-structure prediction [1]. Exarafenib is a pan-RAF inhibitor that is capable of inhibiting aberrant MAPK signalling via both mono- and dimeric RAF structures.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 89.96
Molecular weight 521.26
XLogP 5.13
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC[C@H](Nc1cc(cc(n1)N1CCOCC1)c1cc(ccc1C)NC(=O)N1CC[C@H](C1)CC(F)(F)F)C
Isomeric SMILES Cc1c(cc(cc1)NC(=O)N1CC[C@H](C1)CC(F)(F)F)c1cc(nc(c1)N1CCOCC1)N[C@H](C)CO
InChI InChI=1S/C26H34F3N5O3/c1-17-3-4-21(31-25(36)34-6-5-19(15-34)14-26(27,28)29)13-22(17)20-11-23(30-18(2)16-35)32-24(12-20)33-7-9-37-10-8-33/h3-4,11-13,18-19,35H,5-10,14-16H2,1-2H3,(H,30,32)(H,31,36)/t18-,19+/m1/s1
InChI Key GZMYLSJUNSCMTD-MOPGFXCFSA-N
Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel